arrow
J

Jiang Li

central south university
H指数:32
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Retraction notice to "IL-1β-mediated inflammatory responses in intervertebral disc degeneration: Mechanisms, signaling pathways, and therapeutic potential" [Heliyon 9 (2023) e19951]

撤稿通知,针对“IL-1β介导的椎间盘退变中的炎症反应:机制、信号通路和治疗潜力” [Heliyon 9 (2023) e19951]

Heliyon
IF3.6
2025-08-070
OA
Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial

Tislelizumab加化疗与安慰剂加化疗作为晚期胃或胃食管交界处腺癌的一线治疗: 原理305的随机,双盲,3期试验

2024-05-2810
OA